QA: Aptevo Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001671584_2021_Aptevo_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001671584, Aptevo Therapeutics Inc

  xvar xval
0 AssetsCurrent 47,264,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,815,000
3 remainder_Assets 3,468,000
4 LiabilitiesCurrent 14,539,000
5 LiabilitiesNoncurrent 2,360,000
6 remainder_Liabilities 20,054,000
7 CostOfGoodsAndServicesSold 19,451,587
8 SellingGeneralAndAdministrativeExpense 15,339,540
9 ResearchAndDevelopmentExpense 14,175,419
10 remainder_Expenses 869,533
11 remainder_Revenues 8,267,100
12 remainder_NetIncome 7,802,051
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 53,547,000
1 Liabilities 36,953,000
2 Expenses 49,836,079
3 Revenues 8,267,100
4 StockholdersEquity 16,594,000
5 NetIncome -33,766,928
6 ComprehensiveNetIncome -33,766,928
7 BaseVar 78,202,615
8 EconomicCapitalRatiobeforeLimitedLiability 0.0532
9 EconomicCapitalRatio 1.46

Edgar->Model Mapping

Feature Distribution

Change over Time